Document Detail

Altered plasma and brain disposition of isopropylidene shikimic acid liposome in rats and the brain protection in cerebral ischemia-reperfusion.
MedLine Citation:
PMID:  23020069     Owner:  NLM     Status:  Publisher    
Context: Cerebral ischemia-reperfusion (I/R) injury is a secondary injury caused by oxidative stresses and inflammatory responses after recovery from cerebral ischemia. Brain protective drugs were used to reduce the injury. In order to improve the distribution in brain and enhance the brain-protective efficacy, some pharmaceutical technologies were used to achieve brain targeting delivery. Objective: To investigate the physiological disposition of ISA liposome, and provide references for the further study about high-efficacy brain-protective preparations for I/R injury. Materials and methods: Comparative studies were carried out. The pharmacodynamics in t-MCAO model rats were studied first, and then the pharmacokinetics and brain distribution of the two preparations were determined. Results: At the same dose, the efficacy of ISA liposome was better (P < 0.05). The efficacy was dose dependent, with significant difference of 20 mg/kg (P < 0.01) and indistinctive difference of 10 mg/kg (P = 0.22), compared with vehicle-treated rats. The parameters, T(1/2β), MRT and AUC were different significantly between the two preparations. The enhancement of brain distribution for ISA in the liposome was obvious, with the maximum concentration 7.18 μg/g, while close to zero for the solution group. Discussion and conclusion: ISA liposome could increase the distribution in brain and enhance the efficacy significantly. The results revealed that the liposomal DDS was potential as a novel strategy for the treatment of cerebral I/R injury. In addition, further targeted modification, such as PEG-modified liposomes, which possess a long circulating property in the bloodstream, would further improve the targeting delivery to the brain and lead to more significant efficacy.
Changhai Qu; Jian Ni; Pei Yang; Hui Zhang; Longfei Lin; Jiang Li; Jingchen Tian; Jing Fu; Xingbin Yin; Hui Kong
Related Documents :
11469389 - Octreotide, a somatostatin analogue, fails to inhibit hypoxia-induced retinal neovascul...
9672799 - Reproduction of antiviral effect in an in vivo model of human cytomegalovirus retinal i...
21288459 - Analgesic effects of methanolic extracts of the leaf or root of moringa oleifera on com...
23627549 - Effects of ethanol on vehicle energy efficiency and implications on ethanol life-cycle ...
9793949 - Photodynamic therapy for corneal neovascularization.
10967069 - Dexamethasone and critical effect of timing on retinopathy.
9324069 - Use of inhalation to study the effect of ethanol and ethanol dependence on neonatal mou...
6807599 - Assessment of intestinal permeability in the experimental rat with [3h]cellobiotol and ...
8280389 - Possible anatomical basis of recovery of function after neonatal frontal lesions in rats.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-1
Journal Detail:
Title:  Drug development and industrial pharmacy     Volume:  -     ISSN:  1520-5762     ISO Abbreviation:  Drug Dev Ind Pharm     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802620     Medline TA:  Drug Dev Ind Pharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
School of Chinese Materia Medica, Beijing University of Chinese Medicine , Beijing , P R China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Associations among Patient Characteristics, Health-Related Quality of Life, and Spiritual Well-Being...
Next Document:  'Things you can't learn from books': Teaching recovery from a lived experience perspective.